Atlassian Corp. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Atlassian Corp. filed its Q3 2024 10-Q, reporting revenue growth for the nine-month period.</b>

AI Summary

Atlassian Corp (TEAM) filed a Quarterly Report (10-Q) with the SEC on April 26, 2024. Revenue for the nine months ended March 31, 2024, was $484 million. Revenue for the nine months ended March 31, 2023, was $457 million. Total assets as of December 31, 2023, were not specified. Net income for the period was not specified. The company's fiscal year ends on June 30.

Why It Matters

For investors and stakeholders tracking Atlassian Corp, this filing contains several important signals. The filing provides year-over-year revenue figures for the nine-month period, indicating growth in the company's top line. Key financial details such as net income, EPS, and balance sheet figures are not explicitly detailed in the provided header information, requiring a deeper dive into the full report.

Risk Assessment

Risk Level: — Atlassian Corp shows moderate risk based on this filing. The provided data is limited to header information and does not contain detailed financial statements, making a comprehensive risk assessment impossible.

Analyst Insight

Review the full 10-Q filing to analyze revenue growth drivers, profitability, and balance sheet health.

Revenue Breakdown

Key Numbers

• 484 — Revenue (9 months ended Mar 31, 2024) (USD millions)
• 457 — Revenue (9 months ended Mar 31, 2023) (USD millions)
• 2024-03-31 — Quarterly Period End Date (USD)
• 2024-04-26 — Filing Date (USD)

Key Players & Entities

• Atlassian Corp. (company) — FILER
• Atlassian Corp. (company) — COMPANY CONFORMED NAME
• Atlassian Corp Plc (company) — FORMER COMPANY
• San Francisco (location) — CITY
• 2024-03-31 (date) — CONFORMED PERIOD OF REPORT
• 2024-04-26 (date) — FILED AS OF DATE

FAQ

Industry Context

Atlassian operates in the software industry, providing collaboration and development tools.

Regulatory Implications

The filing is a standard 10-Q, subject to SEC regulations for quarterly financial reporting.

What Investors Should Do

1. Analyze the full 10-Q for detailed financial statements and management discussion.
2. Compare revenue growth to industry benchmarks.
3. Investigate any disclosed risk factors and their potential impact.

Key Dates

• 2024-03-31: Quarter End — Reporting period for the 10-Q.
• 2024-04-26: Filing Date — Date the 10-Q was filed with the SEC.

Year-Over-Year Comparison

The filing covers the period ending March 31, 2024, with revenue reported for the nine months ending on this date, showing an increase compared to the prior year's nine-month period.

Key Financial Figures

• $0.00001 — stered Class A Common Stock, par value $0.00001 per share TEAM Nasdaq Global Select Mar

Filing Documents

• team-20240331.htm (10-Q) — 2000KB
• exhibit311_fy24q3team.htm (EX-31.1) — 8KB
• exhibit312_fy24q3team.htm (EX-31.2) — 8KB
• exhibit313_fy24q3team.htm (EX-31.3) — 8KB
• exhibit321_fy24q3team.htm (EX-32.1) — 14KB
• 0001650372-24-000016.txt (&nbsp;) — 8775KB
• team-20240331.xsd (EX-101.SCH) — 49KB
• team-20240331_cal.xml (EX-101.CAL) — 92KB
• team-20240331_def.xml (EX-101.DEF) — 280KB
• team-20240331_lab.xml (EX-101.LAB) — 649KB
• team-20240331_pre.xml (EX-101.PRE) — 463KB
• team-20240331_htm.xml (XML) — 1447KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 43 Item 4.

Controls and Procedures

Controls and Procedures 44 PART II Item 1.

Legal Proceedings

Legal Proceedings 45 Item 1A.

Risk Factors

Risk Factors 46 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 76 Item 3. Defaults Upon Senior Securities 77 Item 4. Mine Safety Disclosures 77 Item 5. Other Information 77 Item 6. Exhibits 78

SIGNATURES

SIGNATURES 79 2

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

ITEM 1. Financial Statements ATLASSIAN CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands, except par value and share data) (Unaudited) March 31, 2024 June 30, 2023 Assets Current assets: Cash and cash equivalents $ 1,948,978 $ 2,102,550 Marketable securities 163,318 10,000 Accounts receivable, net 646,082 477,678 Prepaid expenses and other current assets 155,551 146,136 Total current assets 2,913,929 2,736,364 Non-current assets: Property and equipment, net 80,961 81,402 Operating lease right-of-use assets 180,967 184,195 Strategic investments 220,125 225,538 Intangible assets, net 312,816 69,072 Goodwill 1,285,745 727,211 Deferred tax assets 2,780 9,945 Other non-current assets 65,942 73,052 Total assets $ 5,063,265 $ 4,106,779 Liabilities and Stockholders' Equity Current liabilities: Accounts payable $ 188,241 $ 159,293 Accrued expenses and other current liabilities 484,896 423,131 Deferred revenue, current portion 1,698,639 1,362,736 Operating lease liabilities, current portion 46,437 44,930 Term loan facility, current portion 50,000 37,500 Total current liabilities 2,468,213 2,027,590 Non-current liabilities: Deferred revenue, net of current portion 256,926 182,743 Operating lease liabilities, net of current portion 225,208 237,835 Term loan facility, net of current portion 924,724 962,093 Deferred tax liabilities 19,036 10,669 Other non-current liabilities 34,987 31,177 Total liabilities 3,929,094 3,452,107 Commitments and contingencies (Note 11) Stockholders' equity Class A Common Stock, $ 0.00001 par value; 750,000,000 shares authorized, 159,483,342 and 152,442,673 issued and outstanding at March 31, 2024 and June 30, 2023, respectively 2 2 Class B Common Stock, 0.00001 par value; 230,000,000 shares authorized, 101,012,393 and 105,124,103 issued and outstanding at March 31, 2024 and June 30, 2023, respectively 1 1 Additional paid-in capital 3,938,577 3,130,631 Accumulated other comprehensive income